BPHL hydrolyses VACV to ACV

Stable Identifier
R-HSA-6784959
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Valacyclovir (VACV) is the 5'-valyl ester prodrug of acyclovir (ACV), an effective anti-herpetic drug. Systemic bioavailability of ACV in humans is up to five times higher when administered orally as the prodrug. After intestinal absorption, valacyclovir hydrolase (BPHL) mediates the rapid and complete hydrolysis to VACV to ACV (Kim et al. 2003, Lai et al. 2008). The subcellular location of human BPHL is unknown but rat Bhpl localises to the mitochondrial membrane (Kim et al. 2003).

Literature References
PubMed ID Title Journal Year
12732646 Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase

Kim, I, Chu, XY, Kim, S, Provoda, CJ, Lee, KD, Amidon, GL

J. Biol. Chem. 2003
18256025 Molecular basis of prodrug activation by human valacyclovirase, an alpha-amino acid ester hydrolase

Lai, L, Xu, Z, Zhou, J, Lee, KD, Amidon, GL

J. Biol. Chem. 2008
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
alpha-amino-acid esterase activity of BPHL [mitochondrial outer membrane]
Physical Entity
Activity
Orthologous Events
Authored
Reviewed
Created